Knee osteoarthritis or degenerative arthritis of the knee is the inflammation of the knee joints. It is a wear and tear, degenerative type of arthritis that is generally affects individuals above the age of 50 years; however, it can also occur in younger individuals. The cartilage in the knee joint gradual wears away in knee osteoarthritis. The knee joint becomes frayed and rough as the protective space in-between the bones reduces as the cartilage wears off. This causes friction in between the bones, which leads to painful bone spurs. The most common cause of this condition include age, rising weight, inherited abnormalities, repetitive stress injuries, heavy & stressful activities, and other illnesses such as rheumatoid arthritis and metabolic disorders. Symptoms of this conditions include swelling, warmth sensation in the joint, knee stiffness, and decrease in mobility.

The global market for Knee Osteoarthritis Treatment was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Knee Osteoarthritis Treatment, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Knee Osteoarthritis Treatment by region & country, by Type, and by Application.

The Knee Osteoarthritis Treatment market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Knee Osteoarthritis Treatment.

Market Segmentation

Scope of Knee Osteoarthritis Treatment - Market Report

Report Metric	Details
Report Name	Knee Osteoarthritis Treatment - Market
CAGR	5%
Segment by Type:	Non-surgical Treatment Surgical Treatment
Segment by Application	Hospitals Ambulatory Surgical Centers Specialty Clinics Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Bioventus, AVM Biotechnology, Anika Therapeutics, Flexion Therapeutics, OrthoTrophix, Sanofi, Horizon Therapeutics, Johnson and Johnson, GlaxoSmithKline, Bayer, Abbott, Pfizer, Eli Lilly
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Knee Osteoarthritis Treatment manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Knee Osteoarthritis Treatment in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Knee Osteoarthritis Treatment in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

FAQ for this report

Who are the main players in the Knee Osteoarthritis Treatment - Market report?

Ans: The main players in the Knee Osteoarthritis Treatment - Market are Bioventus, AVM Biotechnology, Anika Therapeutics, Flexion Therapeutics, OrthoTrophix, Sanofi, Horizon Therapeutics, Johnson and Johnson, GlaxoSmithKline, Bayer, Abbott, Pfizer, Eli Lilly

What are the Application segmentation covered in the Knee Osteoarthritis Treatment - Market report?

Ans: The Applications covered in the Knee Osteoarthritis Treatment - Market report are Hospitals, Ambulatory Surgical Centers, Specialty Clinics, Others

What are the Type segmentation covered in the Knee Osteoarthritis Treatment - Market report?

Ans: The Types covered in the Knee Osteoarthritis Treatment - Market report are Non-surgical Treatment, Surgical Treatment

1 Market Overview

1.1 Knee Osteoarthritis Treatment Product Introduction

1.2 Global Knee Osteoarthritis Treatment Market Size Forecast

1.3 Knee Osteoarthritis Treatment Market Trends & Drivers

1.3.1 Knee Osteoarthritis Treatment Industry Trends

1.3.2 Knee Osteoarthritis Treatment Market Drivers & Opportunity

1.3.3 Knee Osteoarthritis Treatment Market Challenges

1.3.4 Knee Osteoarthritis Treatment Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Knee Osteoarthritis Treatment Players Revenue Ranking (2023)

2.2 Global Knee Osteoarthritis Treatment Revenue by Company (2019-2024)

2.3 Key Companies Knee Osteoarthritis Treatment Manufacturing Base Distribution and Headquarters

2.4 Key Companies Knee Osteoarthritis Treatment Product Offered

2.5 Key Companies Time to Begin Mass Production of Knee Osteoarthritis Treatment

2.6 Knee Osteoarthritis Treatment Market Competitive Analysis

2.6.1 Knee Osteoarthritis Treatment Market Concentration Rate (2019-2024)

2.6.2 Global 5 and 10 Largest Companies by Knee Osteoarthritis Treatment Revenue in 2023

2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Knee Osteoarthritis Treatment as of 2023)

2.7 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Non-surgical Treatment

3.1.2 Surgical Treatment

3.2 Global Knee Osteoarthritis Treatment Sales Value by Type

3.2.1 Global Knee Osteoarthritis Treatment Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global Knee Osteoarthritis Treatment Sales Value, by Type (2019-2030)

3.2.3 Global Knee Osteoarthritis Treatment Sales Value, by Type (%) (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Hospitals

4.1.2 Ambulatory Surgical Centers

4.1.3 Specialty Clinics

4.1.4 Others

4.2 Global Knee Osteoarthritis Treatment Sales Value by Application

4.2.1 Global Knee Osteoarthritis Treatment Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global Knee Osteoarthritis Treatment Sales Value, by Application (2019-2030)

4.2.3 Global Knee Osteoarthritis Treatment Sales Value, by Application (%) (2019-2030)

5 Segmentation by Region

5.1 Global Knee Osteoarthritis Treatment Sales Value by Region

5.1.1 Global Knee Osteoarthritis Treatment Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global Knee Osteoarthritis Treatment Sales Value by Region (2019-2024)

5.1.3 Global Knee Osteoarthritis Treatment Sales Value by Region (2025-2030)

5.1.4 Global Knee Osteoarthritis Treatment Sales Value by Region (%), (2019-2030)

5.2 North America

5.2.1 North America Knee Osteoarthritis Treatment Sales Value, 2019-2030

5.2.2 North America Knee Osteoarthritis Treatment Sales Value by Country (%), 2023 VS 2030

5.3 Europe

5.3.1 Europe Knee Osteoarthritis Treatment Sales Value, 2019-2030

5.3.2 Europe Knee Osteoarthritis Treatment Sales Value by Country (%), 2023 VS 2030

5.4 Asia Pacific

5.4.1 Asia Pacific Knee Osteoarthritis Treatment Sales Value, 2019-2030

5.4.2 Asia Pacific Knee Osteoarthritis Treatment Sales Value by Country (%), 2023 VS 2030

5.5 South America

5.5.1 South America Knee Osteoarthritis Treatment Sales Value, 2019-2030

5.5.2 South America Knee Osteoarthritis Treatment Sales Value by Country (%), 2023 VS 2030

5.6 Middle East & Africa

5.6.1 Middle East & Africa Knee Osteoarthritis Treatment Sales Value, 2019-2030

5.6.2 Middle East & Africa Knee Osteoarthritis Treatment Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Knee Osteoarthritis Treatment Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions Knee Osteoarthritis Treatment Sales Value

6.3 United States

6.3.1 United States Knee Osteoarthritis Treatment Sales Value, 2019-2030

6.3.2 United States Knee Osteoarthritis Treatment Sales Value by Type (%), 2023 VS 2030

6.3.3 United States Knee Osteoarthritis Treatment Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe Knee Osteoarthritis Treatment Sales Value, 2019-2030

6.4.2 Europe Knee Osteoarthritis Treatment Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe Knee Osteoarthritis Treatment Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China Knee Osteoarthritis Treatment Sales Value, 2019-2030

6.5.2 China Knee Osteoarthritis Treatment Sales Value by Type (%), 2023 VS 2030

6.5.3 China Knee Osteoarthritis Treatment Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan Knee Osteoarthritis Treatment Sales Value, 2019-2030

6.6.2 Japan Knee Osteoarthritis Treatment Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan Knee Osteoarthritis Treatment Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea Knee Osteoarthritis Treatment Sales Value, 2019-2030

6.7.2 South Korea Knee Osteoarthritis Treatment Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea Knee Osteoarthritis Treatment Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia Knee Osteoarthritis Treatment Sales Value, 2019-2030

6.8.2 Southeast Asia Knee Osteoarthritis Treatment Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia Knee Osteoarthritis Treatment Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India Knee Osteoarthritis Treatment Sales Value, 2019-2030

6.9.2 India Knee Osteoarthritis Treatment Sales Value by Type (%), 2023 VS 2030

6.9.3 India Knee Osteoarthritis Treatment Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 Bioventus

7.1.1 Bioventus Profile

7.1.2 Bioventus Main Business

7.1.3 Bioventus Knee Osteoarthritis Treatment Products, Services and Solutions

7.1.4 Bioventus Knee Osteoarthritis Treatment Revenue (US$ Million) & (2019-2024)

7.1.5 Bioventus Recent Developments

7.2 AVM Biotechnology

7.2.1 AVM Biotechnology Profile

7.2.2 AVM Biotechnology Main Business

7.2.3 AVM Biotechnology Knee Osteoarthritis Treatment Products, Services and Solutions

7.2.4 AVM Biotechnology Knee Osteoarthritis Treatment Revenue (US$ Million) & (2019-2024)

7.2.5 AVM Biotechnology Recent Developments

7.3 Anika Therapeutics

7.3.1 Anika Therapeutics Profile

7.3.2 Anika Therapeutics Main Business

7.3.3 Anika Therapeutics Knee Osteoarthritis Treatment Products, Services and Solutions

7.3.4 Anika Therapeutics Knee Osteoarthritis Treatment Revenue (US$ Million) & (2019-2024)

7.3.5 Flexion Therapeutics Recent Developments

7.4 Flexion Therapeutics

7.4.1 Flexion Therapeutics Profile

7.4.2 Flexion Therapeutics Main Business

7.4.3 Flexion Therapeutics Knee Osteoarthritis Treatment Products, Services and Solutions

7.4.4 Flexion Therapeutics Knee Osteoarthritis Treatment Revenue (US$ Million) & (2019-2024)

7.4.5 Flexion Therapeutics Recent Developments

7.5 OrthoTrophix

7.5.1 OrthoTrophix Profile

7.5.2 OrthoTrophix Main Business

7.5.3 OrthoTrophix Knee Osteoarthritis Treatment Products, Services and Solutions

7.5.4 OrthoTrophix Knee Osteoarthritis Treatment Revenue (US$ Million) & (2019-2024)

7.5.5 OrthoTrophix Recent Developments

7.6 Sanofi

7.6.1 Sanofi Profile

7.6.2 Sanofi Main Business

7.6.3 Sanofi Knee Osteoarthritis Treatment Products, Services and Solutions

7.6.4 Sanofi Knee Osteoarthritis Treatment Revenue (US$ Million) & (2019-2024)

7.6.5 Sanofi Recent Developments

7.7 Horizon Therapeutics

7.7.1 Horizon Therapeutics Profile

7.7.2 Horizon Therapeutics Main Business

7.7.3 Horizon Therapeutics Knee Osteoarthritis Treatment Products, Services and Solutions

7.7.4 Horizon Therapeutics Knee Osteoarthritis Treatment Revenue (US$ Million) & (2019-2024)

7.7.5 Horizon Therapeutics Recent Developments

7.8 Johnson and Johnson

7.8.1 Johnson and Johnson Profile

7.8.2 Johnson and Johnson Main Business

7.8.3 Johnson and Johnson Knee Osteoarthritis Treatment Products, Services and Solutions

7.8.4 Johnson and Johnson Knee Osteoarthritis Treatment Revenue (US$ Million) & (2019-2024)

7.8.5 Johnson and Johnson Recent Developments

7.9 GlaxoSmithKline

7.9.1 GlaxoSmithKline Profile

7.9.2 GlaxoSmithKline Main Business

7.9.3 GlaxoSmithKline Knee Osteoarthritis Treatment Products, Services and Solutions

7.9.4 GlaxoSmithKline Knee Osteoarthritis Treatment Revenue (US$ Million) & (2019-2024)

7.9.5 GlaxoSmithKline Recent Developments

7.10 Bayer

7.10.1 Bayer Profile

7.10.2 Bayer Main Business

7.10.3 Bayer Knee Osteoarthritis Treatment Products, Services and Solutions

7.10.4 Bayer Knee Osteoarthritis Treatment Revenue (US$ Million) & (2019-2024)

7.10.5 Bayer Recent Developments

7.11 Abbott

7.11.1 Abbott Profile

7.11.2 Abbott Main Business

7.11.3 Abbott Knee Osteoarthritis Treatment Products, Services and Solutions

7.11.4 Abbott Knee Osteoarthritis Treatment Revenue (US$ Million) & (2019-2024)

7.11.5 Abbott Recent Developments

7.12 Pfizer

7.12.1 Pfizer Profile

7.12.2 Pfizer Main Business

7.12.3 Pfizer Knee Osteoarthritis Treatment Products, Services and Solutions

7.12.4 Pfizer Knee Osteoarthritis Treatment Revenue (US$ Million) & (2019-2024)

7.12.5 Pfizer Recent Developments

7.13 Eli Lilly

7.13.1 Eli Lilly Profile

7.13.2 Eli Lilly Main Business

7.13.3 Eli Lilly Knee Osteoarthritis Treatment Products, Services and Solutions

7.13.4 Eli Lilly Knee Osteoarthritis Treatment Revenue (US$ Million) & (2019-2024)

7.13.5 Eli Lilly Recent Developments

8 Industry Chain Analysis

8.1 Knee Osteoarthritis Treatment Industrial Chain

8.2 Knee Osteoarthritis Treatment Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Knee Osteoarthritis Treatment Sales Model

8.5.2 Sales Channel

8.5.3 Knee Osteoarthritis Treatment Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

List of Tables

Table 1. Knee Osteoarthritis Treatment Market Trends

Table 2. Knee Osteoarthritis Treatment Market Drivers & Opportunity

Table 3. Knee Osteoarthritis Treatment Market Challenges

Table 4. Knee Osteoarthritis Treatment Market Restraints

Table 5. Global Knee Osteoarthritis Treatment Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global Knee Osteoarthritis Treatment Revenue Market Share by Company (2019-2024)

Table 7. Key Companies Knee Osteoarthritis Treatment Manufacturing Base Distribution and Headquarters

Table 8. Key Companies Knee Osteoarthritis Treatment Product Type

Table 9. Key Companies Time to Begin Mass Production of Knee Osteoarthritis Treatment

Table 10. Global Knee Osteoarthritis Treatment Companies Market Concentration Ratio (CR5 and HHI)

Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Knee Osteoarthritis Treatment as of 2023)

Table 12. Mergers & Acquisitions, Expansion Plans

Table 13. Global Knee Osteoarthritis Treatment Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 14. Global Knee Osteoarthritis Treatment Sales Value by Type (2019-2024) & (US$ Million)

Table 15. Global Knee Osteoarthritis Treatment Sales Value by Type (2025-2030) & (US$ Million)

Table 16. Global Knee Osteoarthritis Treatment Sales Market Share in Value by Type (2019-2024) & (%)

Table 17. Global Knee Osteoarthritis Treatment Sales Market Share in Value by Type (2025-2030) & (%)

Table 18. Global Knee Osteoarthritis Treatment Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 19. Global Knee Osteoarthritis Treatment Sales Value by Application (2019-2024) & (US$ Million)

Table 20. Global Knee Osteoarthritis Treatment Sales Value by Application (2025-2030) & (US$ Million)

Table 21. Global Knee Osteoarthritis Treatment Sales Market Share in Value by Application (2019-2024) & (%)

Table 22. Global Knee Osteoarthritis Treatment Sales Market Share in Value by Application (2025-2030) & (%)

Table 23. Global Knee Osteoarthritis Treatment Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 24. Global Knee Osteoarthritis Treatment Sales Value by Region (2019-2024) & (US$ Million)

Table 25. Global Knee Osteoarthritis Treatment Sales Value by Region (2025-2030) & (US$ Million)

Table 26. Global Knee Osteoarthritis Treatment Sales Value by Region (2019-2024) & (%)

Table 27. Global Knee Osteoarthritis Treatment Sales Value by Region (2025-2030) & (%)

Table 28. Key Countries/Regions Knee Osteoarthritis Treatment Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 29. Key Countries/Regions Knee Osteoarthritis Treatment Sales Value, (2019-2024) & (US$ Million)

Table 30. Key Countries/Regions Knee Osteoarthritis Treatment Sales Value, (2025-2030) & (US$ Million)

Table 31. Bioventus Basic Information List

Table 32. Bioventus Description and Business Overview

Table 33. Bioventus Knee Osteoarthritis Treatment Products, Services and Solutions

Table 34. Revenue (US$ Million) in Knee Osteoarthritis Treatment Business of Bioventus (2019-2024)

Table 35. Bioventus Recent Developments

Table 36. AVM Biotechnology Basic Information List

Table 37. AVM Biotechnology Description and Business Overview

Table 38. AVM Biotechnology Knee Osteoarthritis Treatment Products, Services and Solutions

Table 39. Revenue (US$ Million) in Knee Osteoarthritis Treatment Business of AVM Biotechnology (2019-2024)

Table 40. AVM Biotechnology Recent Developments

Table 41. Anika Therapeutics Basic Information List

Table 42. Anika Therapeutics Description and Business Overview

Table 43. Anika Therapeutics Knee Osteoarthritis Treatment Products, Services and Solutions

Table 44. Revenue (US$ Million) in Knee Osteoarthritis Treatment Business of Anika Therapeutics (2019-2024)

Table 45. Anika Therapeutics Recent Developments

Table 46. Flexion Therapeutics Basic Information List

Table 47. Flexion Therapeutics Description and Business Overview

Table 48. Flexion Therapeutics Knee Osteoarthritis Treatment Products, Services and Solutions

Table 49. Revenue (US$ Million) in Knee Osteoarthritis Treatment Business of Flexion Therapeutics (2019-2024)

Table 50. Flexion Therapeutics Recent Developments

Table 51. OrthoTrophix Basic Information List

Table 52. OrthoTrophix Description and Business Overview

Table 53. OrthoTrophix Knee Osteoarthritis Treatment Products, Services and Solutions

Table 54. Revenue (US$ Million) in Knee Osteoarthritis Treatment Business of OrthoTrophix (2019-2024)

Table 55. OrthoTrophix Recent Developments

Table 56. Sanofi Basic Information List

Table 57. Sanofi Description and Business Overview

Table 58. Sanofi Knee Osteoarthritis Treatment Products, Services and Solutions

Table 59. Revenue (US$ Million) in Knee Osteoarthritis Treatment Business of Sanofi (2019-2024)

Table 60. Sanofi Recent Developments

Table 61. Horizon Therapeutics Basic Information List

Table 62. Horizon Therapeutics Description and Business Overview

Table 63. Horizon Therapeutics Knee Osteoarthritis Treatment Products, Services and Solutions

Table 64. Revenue (US$ Million) in Knee Osteoarthritis Treatment Business of Horizon Therapeutics (2019-2024)

Table 65. Horizon Therapeutics Recent Developments

Table 66. Johnson and Johnson Basic Information List

Table 67. Johnson and Johnson Description and Business Overview

Table 68. Johnson and Johnson Knee Osteoarthritis Treatment Products, Services and Solutions

Table 69. Revenue (US$ Million) in Knee Osteoarthritis Treatment Business of Johnson and Johnson (2019-2024)

Table 70. Johnson and Johnson Recent Developments

Table 71. GlaxoSmithKline Basic Information List

Table 72. GlaxoSmithKline Description and Business Overview

Table 73. GlaxoSmithKline Knee Osteoarthritis Treatment Products, Services and Solutions

Table 74. Revenue (US$ Million) in Knee Osteoarthritis Treatment Business of GlaxoSmithKline (2019-2024)

Table 75. GlaxoSmithKline Recent Developments

Table 76. Bayer Basic Information List

Table 77. Bayer Description and Business Overview

Table 78. Bayer Knee Osteoarthritis Treatment Products, Services and Solutions

Table 79. Revenue (US$ Million) in Knee Osteoarthritis Treatment Business of Bayer (2019-2024)

Table 80. Bayer Recent Developments

Table 81. Abbott Basic Information List

Table 82. Abbott Description and Business Overview

Table 83. Abbott Knee Osteoarthritis Treatment Products, Services and Solutions

Table 84. Revenue (US$ Million) in Knee Osteoarthritis Treatment Business of Abbott (2019-2024)

Table 85. Abbott Recent Developments

Table 86. Pfizer Basic Information List

Table 87. Pfizer Description and Business Overview

Table 88. Pfizer Knee Osteoarthritis Treatment Products, Services and Solutions

Table 89. Revenue (US$ Million) in Knee Osteoarthritis Treatment Business of Pfizer (2019-2024)

Table 90. Pfizer Recent Developments

Table 91. Eli Lilly Basic Information List

Table 92. Eli Lilly Description and Business Overview

Table 93. Eli Lilly Knee Osteoarthritis Treatment Products, Services and Solutions

Table 94. Revenue (US$ Million) in Knee Osteoarthritis Treatment Business of Eli Lilly (2019-2024)

Table 95. Eli Lilly Recent Developments

Table 96. Key Raw Materials Lists

Table 97. Raw Materials Key Suppliers Lists

Table 98. Knee Osteoarthritis Treatment Downstream Customers

Table 99. Knee Osteoarthritis Treatment Distributors List

Table 100. Research Programs/Design for This Report

Table 101. Key Data Information from Secondary Sources

Table 102. Key Data Information from Primary Sources

Table 103. Business Unit and Senior & Team Lead Analysts

List of Figures

Figure 1. Knee Osteoarthritis Treatment Product Picture

Figure 2. Global Knee Osteoarthritis Treatment Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Knee Osteoarthritis Treatment Sales Value (2019-2030) & (US$ Million)

Figure 4. Knee Osteoarthritis Treatment Report Years Considered

Figure 5. Global Knee Osteoarthritis Treatment Players Revenue Ranking (2023) & (US$ Million)

Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Knee Osteoarthritis Treatment Revenue in 2023

Figure 7. Knee Osteoarthritis Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 8. Non-surgical Treatment Picture

Figure 9. Surgical Treatment Picture

Figure 10. Global Knee Osteoarthritis Treatment Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 11. Global Knee Osteoarthritis Treatment Sales Value Market Share by Type, 2023 & 2030

Figure 12. Product Picture of Hospitals

Figure 13. Product Picture of Ambulatory Surgical Centers

Figure 14. Product Picture of Specialty Clinics

Figure 15. Product Picture of Others

Figure 16. Global Knee Osteoarthritis Treatment Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 17. Global Knee Osteoarthritis Treatment Sales Value Market Share by Application, 2023 & 2030

Figure 18. North America Knee Osteoarthritis Treatment Sales Value (2019-2030) & (US$ Million)

Figure 19. North America Knee Osteoarthritis Treatment Sales Value by Country (%), 2023 VS 2030

Figure 20. Europe Knee Osteoarthritis Treatment Sales Value (2019-2030) & (US$ Million)

Figure 21. Europe Knee Osteoarthritis Treatment Sales Value by Country (%), 2023 VS 2030

Figure 22. Asia Pacific Knee Osteoarthritis Treatment Sales Value (2019-2030) & (US$ Million)

Figure 23. Asia Pacific Knee Osteoarthritis Treatment Sales Value by Country (%), 2023 VS 2030

Figure 24. South America Knee Osteoarthritis Treatment Sales Value (2019-2030) & (US$ Million)

Figure 25. South America Knee Osteoarthritis Treatment Sales Value by Country (%), 2023 VS 2030

Figure 26. Middle East & Africa Knee Osteoarthritis Treatment Sales Value (2019-2030) & (US$ Million)

Figure 27. Middle East & Africa Knee Osteoarthritis Treatment Sales Value by Country (%), 2023 VS 2030

Figure 28. Key Countries/Regions Knee Osteoarthritis Treatment Sales Value (%), (2019-2030)

Figure 29. United States Knee Osteoarthritis Treatment Sales Value, (2019-2030) & (US$ Million)

Figure 30. United States Knee Osteoarthritis Treatment Sales Value by Type (%), 2023 VS 2030

Figure 31. United States Knee Osteoarthritis Treatment Sales Value by Application (%), 2023 VS 2030

Figure 32. Europe Knee Osteoarthritis Treatment Sales Value, (2019-2030) & (US$ Million)

Figure 33. Europe Knee Osteoarthritis Treatment Sales Value by Type (%), 2023 VS 2030

Figure 34. Europe Knee Osteoarthritis Treatment Sales Value by Application (%), 2023 VS 2030

Figure 35. China Knee Osteoarthritis Treatment Sales Value, (2019-2030) & (US$ Million)

Figure 36. China Knee Osteoarthritis Treatment Sales Value by Type (%), 2023 VS 2030

Figure 37. China Knee Osteoarthritis Treatment Sales Value by Application (%), 2023 VS 2030

Figure 38. Japan Knee Osteoarthritis Treatment Sales Value, (2019-2030) & (US$ Million)

Figure 39. Japan Knee Osteoarthritis Treatment Sales Value by Type (%), 2023 VS 2030

Figure 40. Japan Knee Osteoarthritis Treatment Sales Value by Application (%), 2023 VS 2030

Figure 41. South Korea Knee Osteoarthritis Treatment Sales Value, (2019-2030) & (US$ Million)

Figure 42. South Korea Knee Osteoarthritis Treatment Sales Value by Type (%), 2023 VS 2030

Figure 43. South Korea Knee Osteoarthritis Treatment Sales Value by Application (%), 2023 VS 2030

Figure 44. Southeast Asia Knee Osteoarthritis Treatment Sales Value, (2019-2030) & (US$ Million)

Figure 45. Southeast Asia Knee Osteoarthritis Treatment Sales Value by Type (%), 2023 VS 2030

Figure 46. Southeast Asia Knee Osteoarthritis Treatment Sales Value by Application (%), 2023 VS 2030

Figure 47. India Knee Osteoarthritis Treatment Sales Value, (2019-2030) & (US$ Million)

Figure 48. India Knee Osteoarthritis Treatment Sales Value by Type (%), 2023 VS 2030

Figure 49. India Knee Osteoarthritis Treatment Sales Value by Application (%), 2023 VS 2030

Figure 50. Knee Osteoarthritis Treatment Industrial Chain

Figure 51. Knee Osteoarthritis Treatment Manufacturing Cost Structure

Figure 52. Channels of Distribution (Direct Sales, and Distribution)

Figure 53. Bottom-up and Top-down Approaches for This Report

Figure 54. Data Triangulation

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3950

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Viscosupplementation for Knee Osteoarthritis Market

Knee Osteoarthritis Treatment Market

Osteoarthritis Pain Market

Osteoarthritis Drugs Market

Osteoarthritis Medications Market

Hip Replacement Market

Rheumatology Therapeutics Market

Total Hip Replacement Market

Psoriatic Arthritis Therapeutics Market

Digital Therapeutics Market

RELATED REPORTS

Global Rheumatoid Arthritis Testing Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-33E11182

Tue Mar 18 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

Global Rheumatoid Arthritis Medicine Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-27I11141

Wed Jan 15 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

Global Rheumatic Disorders Drug Market Insights, Forecast to 2030

120 Pages

Type: Report

Code: QYRE-Auto-34K5776

Fri Dec 27 00:00:00 UTC 2024

$9800

Enterprise User

Add to Cart

Global Rheumatoid Arthritis Diagnostic Device Market Insights, Forecast to 2030

120 Pages

Type: Report

Code: QYRE-Auto-0S6275

Fri Dec 27 00:00:00 UTC 2024

$9800

Enterprise User

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions